Follow the 엠젠솔루션 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 엠젠솔루션 has recorded 35 public disclosures. The latest transaction was filed on 29 June 2026 (Sale). Among the most active insiders: 트렌스젠바이오. All data is openly available.
35
Insider Decl.
n/a
Thresholds
n/a
28 ops.
Buy Volume
n/a
5 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
엠젠솔루션 is a company listed on the XKRX, specializing in the healthcare and pharmaceutical sector. It focuses on developing innovative solutions to enhance healthcare.